Home | Site Map | Contact | Directions
Ceregene

Science

3 Generations Science at Ceregene »
Neurotrophic Factors »
Gene Delivery Technology »

Clinical Programs

Participate in a Clinical Trial:

Phase 2 Parkinson's Disease
For enrollment information, see www.clinicaltrials.gov
or www.pdtrials.org

Phase 2 Alzheimer's Disease
In collaboration with Alzheimer's Disease Cooperative Study (ADCS)
For enrollment information, see www.clinicaltrials.gov
or www.adcs.org

Newsroom

06-22-10: The Michael J. Fox Foundation
Awards $2.5 Million to Support Ceregene's
New Phase 2 Neurturin Clinical Study for Parkinson's Disease »
04-28-10: Ceregene Has Initiated a New
Phase 1/2 Clinical Trial of CERE-120 for Parkinson's Disease »

Company
Science
Pipeline
Clinical Programs
Business Development
Newsroom
Contact